Investigation of Prevenar (pneumococcal 7-valent conjugate vaccine) administration for post-marketing surveillance
Phase of Trial: Phase IV
Latest Information Update: 24 Sep 2008
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Adverse reactions
- Sponsors Wyeth
- 24 Sep 2008 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
- 24 Sep 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Dec 2005 New trial record.